This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Latest papers
CAP-ACP Workload Model for Advanced Diagnostics in Precision Medicine.
American journal of clinical pathology · 2022
T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10.
Blood · 2017
Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.
Clinical chemistry · 2016
Latest funding
- $573,752
Development of the first pre-operative serum exosomal miRNA test to guide treatment decision in prostate cancer
CIHR · 2018 · Nominated PI
- $105,000
Identification of molecular markers for the assessment of aggressive behaviour of small renal masses
CIHR · 2015 · Supervisor
- $75,625
Understanding the role of miRNAs in cancer stem cell formation and maintenance in kidney cancer
CIHR · 2014 · Supervisor
3 publications.
CAP-ACP Workload Model for Advanced Diagnostics in Precision Medicine.
Park PC, Kurek KC, DeCoteau J, Howlett CJ, Hawkins C, Izevbaye I, Carter MD, Redpath M, Lo B, Alex D, Yousef G, Yip S, Maung R
T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10.
Kapur R, Kim M, Aslam R, McVey MJ, Tabuchi A, Luo A, Liu J, Li Y, Shanmugabhavananthan S, Speck ER, Zufferey A, Yousef G, Zhang H, Rondina MT, Weyrich AS, Porcelijn L, Kuebler WM, Slutsky AS, Semple JW
Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.
Markou A, Zavridou M, Sourvinou I, Yousef G, Kounelis S, Malamos N, Georgoulias V, Lianidou E
Development of the first pre-operative serum exosomal miRNA test to guide treatment decision in prostate cancer
Principal investigators: Yousef, George M; Fleshner, Neil E; Xu, Wei
Keywords: Active Surveillance; Exosomal Mirnas; Liquid Biopsy; Prostate Cancer
Identification of molecular markers for the assessment of aggressive behaviour of small renal masses
Principal investigators: Di Meo, Ashley
Keywords: Biomarkers; Mass Spectrometry; Micrornas; Peptidomics; Prognosis; Proteomics; Renal Cell Carcinoma; Rt-Pcr; Tumor Markers
Understanding the role of miRNAs in cancer stem cell formation and maintenance in kidney cancer
Principal investigators: Lichner, Zsuzsanna
Keywords: Cancer Stem Cell; Clear Cell Renal Cell Carcinoma; Microrna; Next Generation Sequencing; Signaling Pathways; Xenograft Tumor Model
Identification of new biomarkers and elucidating the pathogenesis of kidney cancer through quantitative proteomic analysis: A new era of personalized medicine
Principal investigators: White, Nicole
Keywords: Bioinformatics; Diagnostic Markers; Kidney Cancer; Mass Spectrometry; Pathways Analysis; Personalized Medicine; Prognostic Markers; Proteomics; Renal Cell Carcinoma; Tumor Markers
The Role of microRNAs in Renal Cell Carcinoma Pathogenesis and their Clinical Utility as Tumor Markers
Principal investigators: Yousef, George M
Keywords: Diagnostic Markers; Kidney Cancer; Kidney Cancer Subtypes; Microrna; Personalized Medicine; Renal Cell Carcinoma; Serum Tumor Markers; Tumor Biomarker; Urine Tumor Markers; Vhl
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Pathology and Laboratory Medicine
- Department of Laboratory Medicine and Pathobiology
- Anesthesia
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.